Gerald D. Cagle, Director at Clearside Biomedical, Inc. (CLSD), bought 28,128 shares at $7.10 ($200K) on 2017-03-27, disclosed to the SEC on 2017-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.10 | 14,064 | $100K | 50.0% |
| 2 | $7.10 | 14,064 | $100K | 50.0% |
| Total | $7.10 avg | 28,128 | $200K | 100% |
| Filing → |
| AERI | BUY | 2018-05-25 | $49K | — | Filing → |
| AERI | BUY | 2018-05-22 | $50K | — | Filing → |
| CLSD | BUY | 2018-03-23 | $89K | — | Filing → |